-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Monoclonal Gammopathies of Clinical Significance

Program: Education Program
Session: Monoclonal Gammopathies of Determined Significance
Sunday, December 6, 2020, 1:55 PM-2:00 PM

Angela Dispenzieri, MD

Division of Hematology, Mayo Clinic, Rochester, MN

Disclosures: Dispenzieri: Alnylam: Research Funding; Celgene: Research Funding; Janssen: Research Funding; Takeda: Research Funding; Intellia: Research Funding; Pfizer: Research Funding.

OffLabel Disclosure:

See more of: Monoclonal Gammopathies of Determined Significance
See more of: Education Program
<< Previous Presentation | Next Presentation